Compare Synchrony Financial (SYF) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Synchrony Financial vs GeneDx Holdings Corp — how do they compare? Synchrony Financial trades at $71.7 (market cap $24.69B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Synchrony Financial is far larger — about 13.7× GeneDx Holdings Corp's market cap, and Synchrony Financial pays a 1.63% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| SYF | WGS | |
|---|---|---|
Market Cap | $24.69B | $1.80B |
Sector | Financials | Technology |
52-Week High | $88.47 | $167.51 |
52-Week Low | $63.78 | $34.51 |
Dividend Yield | 1.63% | — |
Enterprise Value | — | $1.80B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Synchrony Financial
Synchrony Financial is a premier consumer financial services company and the largest provider of private-label credit cards in the United States. Spun off from GE Capital in 2014, it operates through a unique B2B2C model, embedding its financing products within the ecosystems of major partners like Amazon, Lowe’s, and PayPal. Synchrony leverages deep data analytics and a diverse multi-platform strategy—spanning retail, health, and auto—to drive customer loyalty and provide specialized credit solutions at the point of sale.
Read more on SYF →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
